65 III. Les épizooties de peste aviaire en France et en, p.70 ,
Prise en charge d'un foyer de peste aviaire, p.74 ,
90 a) Les réseaux de laboratoire 90 b) Les réseaux de surveillance en population, p.90 ,
Dix-huit personnes sont infectées, il y aura six décès. Mais la maladie est contenue après l'extermination des poulets contaminés 6 ,
Kazakhstan et en Mongolie que l'on retrouve le virus. Le même mois, il fait sa première apparition européenne en Russie ,
Allemagne a connu un grand nombre de cas dans la faune sauvage, 2006. ,
de nombreux oiseaux sauvages ont été retrouvés morts sur l'île de Rügen. Il s'agissait de cygnes mais également de canards et d'oies ,
quatorze pays déclarent un foyer initial chez les oiseaux sauvages, 2006. ,
la République tchèque, toujours chez les oiseaux sauvages. Le même mois, le Pakistan, l'Albanie, le Cameroun, la Suède, l'Israël, l'Afghanistan, la Jordanie déclarent le virus au sein des volailles d'élevage ,
soixante et un pays ont déclaré l'influenza aviaire hautement pathogène à virus H5N1 chez des volailles d'élevage ou des oiseaux sauvages. Nous nous apercevons que le continent américain et l'Océanie sont indemnes. 2. Chez l'homme BIBLIOGRAPHIE, 2003. ,
Recherches de pathologie comparée, Eds Cassel chez H. Hotop, 1853. ,
Recherches de pathologie comparée, Eds Cassel chez H. Hotop, 1853. ,
Animal plagues : their history, nature and prevention, 1821. ,
DOI : 10.5962/bhl.title.100003
Histoire de la surveillance et du contrôle des maladies animales transmissibles. Eds Office international des épizooties, 2000. ,
Les virus à ARN : famille des Orthomyxoviridae, Virologie humaine et animale, cours, fiches de synthèse et QCM, pp.212-215, 2005. ,
La grippe, Annales de l'Institut Pasteur / Actualit??s, vol.6, issue.1, 2003. ,
DOI : 10.1016/0924-4204(96)83604-3
Orthomyxoviridae In: Traité de virologie médicale Eds Huraux, pp.439-457, 2003. ,
Orthomyxoviridés In : Classification et nomenclature des virus ., 5 ème rapport du Comité International de Taxonomie des Virus, pp.253-261, 1994. ,
Infections à Orthomyxoviridus, pp.107-112, 1992. ,
Structure et variation des virus grippaux In : Grippe et infections virales des voies aériennes supérieures, tome 1, Guides Médi, p.51, 2001. ,
Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls, Journal of Virology, vol.79, issue.5, pp.2814-2822, 2005. ,
DOI : 10.1128/JVI.79.5.2814-2822.2005
Pandémie : la grande menace. Grippe aviaire : 500000 morts en France ? Eds Fayard, 2005. ,
THE ORIGINS OF NEW PANDEMIC VIRUSES: The Acquisition of New Host Ranges by Canine Parvovirus and Influenza A Viruses, Annual Review of Microbiology, vol.59, issue.1, pp.553-586, 2005. ,
DOI : 10.1146/annurev.micro.59.030804.121059
Evaluation, contrôle et prévention du risque de transmission du virus influenza aviaire à l'homme, Ann. Med. Vét, vol.148, pp.65-77, 2004. ,
Receptor determinants of human and animal influenza virus isolates: Differences in receptor specificity of the H3 hemagglutinin based on species of origin, Virology, vol.127, issue.2, pp.361-373, 1983. ,
DOI : 10.1016/0042-6822(83)90150-2
Influenza type A in humans, mammals and birds: Determinants of virus virulence, host-range and interspecies transmission, BioEssays, vol.176, issue.7, pp.657-671, 2003. ,
DOI : 10.1086/514177
Host Mediated Variation and Receptor Binding Specificity of Influenza Viruses, Adv Exp Med Biol, vol.491, pp.445-451, 2001. ,
DOI : 10.1007/978-1-4615-1267-7_29
Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses, Biological and Pharmaceutical Bulletin, vol.28, issue.3, pp.399-408, 2005. ,
DOI : 10.1248/bpb.28.399
Orthomyxoviridae: les virus influenza, Presses universitaires de Lyon, pp.407-420, 2002. ,
Textbook of Influenza, 1998. ,
Orthomyxoviridae : the viruses and their replication, 2001. ,
Inactivation of Avian Influenza Viruses by Chemical Agents and Physical Conditions: A Review, Zoonoses and Public Health, vol.68, issue.Suppl. 3, pp.51-68, 2007. ,
DOI : 10.3201/eid1004.030396
Lethality to Ferrets of H5N1 Influenza Viruses Isolated from Humans and Poultry in 2004, Journal of Virology, vol.79, issue.4, pp.2191-2198, 2005. ,
DOI : 10.1128/JVI.79.4.2191-2198.2005
Structural features of the avian influenza virus hemagglutinin that influence virulence, Veterinary Microbiology, vol.74, issue.1-2, pp.77-86, 2000. ,
DOI : 10.1016/S0378-1135(00)00168-1
Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses, Science, vol.293, issue.5536, pp.1840-1842, 2001. ,
DOI : 10.1126/science.1062882
Molecular Determinants within the Surface Proteins Involved in the Pathogenicity of H5N1 Influenza Viruses in Chickens, Journal of Virology, vol.78, issue.18, pp.9954-9964, 2004. ,
DOI : 10.1128/JVI.78.18.9954-9964.2004
Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture, Virus Research, vol.79, issue.1-2, pp.177-185, 2001. ,
DOI : 10.1016/S0168-1702(01)00272-6
PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice, Virology, vol.320, issue.2, pp.258-266, 2004. ,
DOI : 10.1016/j.virol.2003.11.030
RETRACTED: The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses, Virus Research, vol.103, issue.1-2, pp.107-113, 2004. ,
DOI : 10.1016/j.virusres.2004.02.022
Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses, Journal of General Virology, vol.86, issue.4, pp.1121-1130, 2005. ,
DOI : 10.1099/vir.0.80663-0
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?, The Lancet, vol.360, issue.9348, pp.1831-1837, 2002. ,
DOI : 10.1016/S0140-6736(02)11772-7
Influenza Virus Virulence and Its Molecular Determinants, Adv Virus Res, vol.65, pp.121-145, 2005. ,
DOI : 10.1016/S0065-3527(05)65004-X
Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada, Journal of Medical Virology, vol.224, issue.4, pp.589-595, 2002. ,
DOI : 10.1006/viro.1996.0519
Bases moléculaires de la variabilité et diffusion des virus grippaux. (Molecular basis of influenza virus variability and diffusion), 2000. ,
Host range of avian influenza virus in free-living birds, Veterinary Research Communications, vol.3, issue.1, pp.125-141, 1988. ,
DOI : 10.7883/yoken1952.31.407
A review of avian influenza in different bird species, Veterinary Microbiology, vol.74, issue.1-2, pp.3-13, 2000. ,
DOI : 10.1016/S0378-1135(00)00160-7
The epidemiology and control of avian influenza and Newcastle disease, Journal of Comparative Pathology, vol.112, issue.2, pp.105-126, 1995. ,
DOI : 10.1016/S0021-9975(05)80054-4
Isolation of Avian Influenza Virus (Subtype H5N2) from Chicken Eggs during a Natural Outbreak, Avian Diseases, vol.29, issue.4, pp.1195-1200, 1985. ,
DOI : 10.2307/1590473
Influenza, pp.583-605, 1997. ,
Human influenza virus A/HongKong, H5N1) infection, pp.977-978, 1998. ,
Mechanisms of Pathogenicity of Influenza A (H5N1) Viruses in Mice, Avian Diseases, vol.47, issue.s3, pp.1131-1134, 2003. ,
DOI : 10.1637/0005-2086-47.s3.1131
Studies of H5N1 Influenza Virus Infection of Pigs by Using Viruses Isolated in Vietnam and Thailand in 2004, Journal of Virology, vol.79, issue.16, pp.10821-10825, 2005. ,
DOI : 10.1128/JVI.79.16.10821-10825.2005
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004, J Virol, vol.79, pp.2191-2198, 2005. ,
Zoo tigers succumb to avian influenza, The Lancet Infectious Diseases, vol.4, issue.12, p.716, 2004. ,
DOI : 10.1016/S1473-3099(04)01216-2
A standard haemagglutination inhibition test for Newcastle disease. (1). A comparison of macro and micro methods, Veterinary Record, vol.95, issue.6, pp.120-123, 1974. ,
DOI : 10.1136/vr.95.6.120
Demonstration of type specific influenza antibody in mammalian and avian serum by immunodiffusion, Bull. World Health Organ, vol.42, pp.779-785, 1970. ,
La vaccination en tant qu'outil utilisable contre l'influenza aviaire, Organisation Mondiale de la Santé animale. 71 ème session générale du Comité International, pp.18-23, 2003. ,
Highly pathogenic avian influenza, Revue Scientifique et Technique de l'OIE, vol.19, issue.2, pp.463-482, 2000. ,
DOI : 10.20506/rst.19.2.1230
URL : https://hal.archives-ouvertes.fr/hal-01290641
Vaccination for avian influenza in Italy, Vet. Rec, vol.147, p.751, 2000. ,
Protection of Chickens against Highly Pathogenic Avian Influenza Virus (H5N2) by Recombinant Fowlpox Viruses, Avian Diseases, vol.35, issue.2, 1991. ,
DOI : 10.2307/1591189
Effect of Route of Administration on the Efficacy of a Recombinant Fowlpox Virus against H5N2 Avian Influenza, Avian Diseases, vol.36, issue.4, pp.1052-1055, 1992. ,
DOI : 10.2307/1591573
Efficacy of Recombinant Fowl Poxvirus Vaccine in Protecting Chickens against a Highly Pathogenic Mexican-Origin H5N2 Avian Influenza Virus, Avian Diseases, vol.41, issue.4, pp.910-922, 1997. ,
DOI : 10.2307/1592346
Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert, Vaccine, vol.18, issue.11-12, pp.1088-1095, 2000. ,
DOI : 10.1016/S0264-410X(99)00369-2
Immunity to Mexican H5N2 Avian Influenza Viruses Induced by a Fowl Pox-H5 Recombinant, Avian Diseases, vol.40, issue.2, pp.461-465, 1996. ,
DOI : 10.2307/1592246
Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene, Vaccine, vol.19, issue.30, pp.4249-4259, 2001. ,
DOI : 10.1016/S0264-410X(01)00167-0
Lowpathogenicity avian influenza (LPAI) in Italy (2002-01): epidemiology and control, 2003. ,
Avian influenza A(H5N1), J Clin Virol, vol.35, pp.2-13, 2006. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00589027
Human infection by avian influenza AH5N1, Hong Kong Med J, vol.11, pp.189-199, 2005. ,
Avian Influenza Virus Infection of Children in Vietnam and Thailand, The Pediatric Infectious Disease Journal, vol.23, issue.8, pp.793-794, 2004. ,
DOI : 10.1097/00006454-200408000-00024
Outbreak of Avian Influenza A(H5N1) Virus Infection in Hong Kong in 1997, Clinical Infectious Diseases, vol.354, issue.Suppl, pp.58-64, 2002. ,
DOI : 10.1016/S0140-6736(99)03311-5
A Child With Avian Influenza A (H5N1) Infection, The Pediatric Infectious Disease Journal, vol.24, issue.2, 2005. ,
DOI : 10.1097/01.inf.0000151037.25237.1e
Avian influenza A(H5N1) infection in humans, N Engl J Med, vol.353, pp.1374-1385, 2005. ,
Atypical avian influenza (H5N1), Emerg Infect Dis, vol.10, pp.1321-1324, 2004. ,
Diarrhoea as a presentation of bird flu infection: a summary on its correlation to outcome in Thai cases, Gut, vol.54, issue.10, p.1506, 2005. ,
DOI : 10.1136/gut.2005.072488
Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by Coma, New England Journal of Medicine, vol.352, issue.7, pp.686-691, 2005. ,
DOI : 10.1056/NEJMoa044307
Antibody Response in Individuals Infected with Avian Influenza A (H5N1) Viruses and Detection of Anti???H5 Antibody among Household and Social Contacts, The Journal of Infectious Diseases, vol.180, issue.6, pp.1763-1770, 1999. ,
DOI : 10.1086/315137
Risk of Influenza A (H5N1) Infection among Health Care Workers Exposed to Patients with Influenza A (H5N1), Hong Kong, The Journal of Infectious Diseases, vol.181, issue.1, pp.344-348, 2000. ,
DOI : 10.1086/315213
Risk of Influenza A (H5N1) Infection among Poultry Workers, Hong Kong, 1997???1998, The Journal of Infectious Diseases, vol.185, issue.8, pp.1005-1010, 1997. ,
DOI : 10.1086/340044
Prevention and early treatment of influenza in healthy adults, Vaccine, vol.18, issue.11-12, pp.957-1030, 2000. ,
DOI : 10.1016/S0264-410X(99)00332-1
A review of vaccine research and development: Human acute respiratory infections, Vaccine, vol.23, issue.50, pp.5708-5724, 2005. ,
DOI : 10.1016/j.vaccine.2005.07.046
Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention, Trends in Pharmacological Sciences, vol.28, issue.6, pp.280-285, 2007. ,
DOI : 10.1016/j.tips.2007.04.005
Current and future antiviral therapy of severe seasonal and avian influenza, Antiviral Research, vol.78, issue.1, pp.91-102, 2008. ,
DOI : 10.1016/j.antiviral.2008.01.003
Heterocyclic rimantadine analogues with antiviral activity, Bioorganic & Medicinal Chemistry, vol.14, issue.10, pp.3341-3348, 2006. ,
DOI : 10.1016/j.bmc.2005.12.056
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus, The Lancet Infectious Diseases, vol.7, issue.1, pp.21-31, 2007. ,
DOI : 10.1016/S1473-3099(06)70684-3
Broad-spectrum antiviral activity of virazole: 1-?-D-ribofuranosyl-1, Science, vol.2, issue.177, pp.4-7, 1972. ,
Molecular strategies to inhibit the replication of RNA viruses, Antiviral Research, vol.78, issue.1, pp.9-25, 2008. ,
DOI : 10.1016/j.antiviral.2008.01.004
Lack of Effect of Oral Ribavirin in Naturally Occurring Influenza A Virus (H1N1) Infection, Journal of Infectious Diseases, vol.141, issue.5, pp.548-554, 1980. ,
DOI : 10.1093/infdis/141.5.548
Oral ribavirin treatment of influenza A and B., Antimicrobial Agents and Chemotherapy, vol.31, issue.8, 1987. ,
DOI : 10.1128/AAC.31.8.1285
In vitro and in vivo influenza virus-inhibitory effects of viramidine, Antiviral Research, vol.68, issue.1, pp.10-17, 2005. ,
DOI : 10.1016/j.antiviral.2005.06.003
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705, Antimicrobial Agents and Chemotherapy, vol.46, issue.4, pp.977-981, 2002. ,
DOI : 10.1128/AAC.46.4.977-981.2002
Mechanism of Action of T-705 against Influenza Virus, Antimicrobial Agents and Chemotherapy, vol.49, issue.3, pp.981-986, 2005. ,
DOI : 10.1128/AAC.49.3.981-986.2005
In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections, vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections, pp.3168-3176, 2007. ,
DOI : 10.1128/AAC.00356-07
Efficacy of Orally Administered T-705 on Lethal Avian Influenza A (H5N1) Virus Infections in Mice, Antimicrobial Agents and Chemotherapy, vol.51, issue.3, pp.845-851, 2007. ,
DOI : 10.1128/AAC.01051-06
Activities of T-705 and Oseltamivir against Influenza Virus, Antiviral Chemistry and Chemotherapy, vol.67, issue.5, pp.235-241, 2003. ,
DOI : 10.1016/S0166-3542(01)00124-3
Inhibition of influenza virus production in virus-infected mice by RNA interference, Proc. Natl. Acad. Sci, 2004. ,
DOI : 10.3201/eid0805.010476
Inhibition of Multiple Subtypes of Influenza A Virus in Cell Cultures with Morpholino Oligomers, Antimicrobial Agents and Chemotherapy, vol.50, issue.11, pp.3724-3733, 2006. ,
DOI : 10.1128/AAC.00644-06
Pathology of fatal human infection associated with avian influenza A H5N1 virus, Journal of Medical Virology, vol.351, issue.3, pp.242-246, 2001. ,
DOI : 10.1016/S0140-6736(98)01182-9
Inhibition of highly pathogenic avian H5N1 influenza virus replication by RNA oligonucleotides targeting NS1 gene, Biochemical and Biophysical Research Communications, vol.365, issue.2, pp.369-374, 2008. ,
DOI : 10.1016/j.bbrc.2007.10.196
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A, Antiviral research, vol.1569799, issue.48, pp.101-115, 1074. ,
Avian flu: isolation of drug-resistant H5N1 virus, Nature, vol.437, pp.1108-139, 2005. ,
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies, Drug Metab. Dispos, vol.30, pp.13-19, 2002. ,
Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice, The Journal of Infectious Diseases, vol.192, issue.4, pp.665-672, 2005. ,
DOI : 10.1086/432008
Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase, 1998. ,
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of, 2001. ,
In Vitro Characterization of A-315675, a Highly Potent Inhibitor of A and B Strain Influenza Virus Neuraminidases and Influenza Virus Replication, Antimicrobial Agents and Chemotherapy, vol.46, issue.4, pp.1014-1021, 2002. ,
DOI : 10.1128/AAC.46.4.1014-1021.2002
Susceptibilities of Antiviral-Resistant Influenza Viruses to Novel Neuraminidase Inhibitors, Antimicrobial Agents and Chemotherapy, vol.49, issue.11, pp.4515-4520, 2005. ,
DOI : 10.1128/AAC.49.11.4515-4520.2005
Role of combination antiviral therapy in pandemic influenza and stockpiling implications, BMJ, vol.334, issue.7588, pp.293-294, 2007. ,
DOI : 10.1136/bmj.39105.428981.BE
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza, Antivir. Ther, vol.8, pp.183-190, 2003. ,
Implementation of the Community Network of Reference Laboratories for Human Influenza in Europe, Journal of Clinical Virology, vol.34, issue.2, pp.87-96, 2005. ,
DOI : 10.1016/j.jcv.2005.02.005
Expression of hemagglutinin protein from the avian influenza virus H5N1 in a baculovirus/insect cell system significantly enhanced by suspension culture, BMC Microbiol, vol.6, pp.16-141, 2006. ,
Recombinant influenza A virus vaccines for the pathogenic human A, H5N1) viruses, pp.1132-1138, 1999. ,
Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics, Virology, vol.305, pp.192-200, 2003. ,
The development and characterization of H5 influenza virus, 2003. ,
Safety and antigenicity of non-adjuvanted and MF59- adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine : a randomised trial of two potential vaccines against H5N1 influenza, Lancet, issue.9272, pp.357-1937, 2001. ,
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans, 2001. ,
Oseltamivir, Drugs, vol.171, issue.9, pp.263-283, 2001. ,
DOI : 10.2165/00003495-200161020-00011
Neuraminidase inhibitors : Zanamivir and oseltamivir. (The) Annals of pharmacotherapy, pp.57-70, 2001. ,
Oseltamivir (Tamiflu??) and its potential for use in the event of an influenza pandemic, Journal of Antimicrobial Chemotherapy, vol.55, issue.suppl_1, pp.5-21, 2005. ,
DOI : 10.1093/jac/dki018
Avian flu: isolation of drug-resistant H5N1 virus, Nature, vol.437, p.1108, 2005. ,
La longue histoire des pestes aviaires, In : Site de l'Académie vétérinaire de France, 2007. ,
Actualités sur la grippe aviaire et sa transmission chez l'homme In : Site du CNRS et de l'INIST, la grippe aviaire et l'homme, le dossier de synthèse, 2006. ,
Dossier d'actualité : ce qu'il faut savoir sur l'influenza aviaire ou grippe aviaire In : Site de l'Ecole Nationale Vétérinaire de Toulouse, 2006. ,
Grippe aviaire : questions fréquemment posées In : Site de l'OMS, 2005. ,
Areas reported confirmed occurrence of H5N1 avian influenza in poultry and wild birds since, 2003. ,
Comment faire face à la menace d'une pandémie de grippe aviaire. Mesures stratégiques recommandées, 2005. ,
Grippe saisonnière :prévention des épidémies et du risque nosocomial, 2008. ,
Notion d'information sur le dispositif de surveillance et de prévention de l'influenza aviaire chez les oiseaux captifs, retenu pour l'automne et l'hiver des années, 2006. ,
ou grippe du poulet ou influenza aviaire) : risques infectieux en milieu de soins, Site du Ministère de la Santé, 2008. ,
indispensable préparation à une pandémie. Les Nouvelles Pharmaceutiques, n°309, 1 er décembre, 2005. ,
Influenza aviaire : protection des éleveurs et professionnels au contact avec des volailles vivantes, 2006. ,
Grippe aviaire et oiseaux des villes et des campagnes : face à la grippe aviaire vis-à-vis des oiseaux sauvages, 2008. ,
Les volailles et oeufs bien cuits ne présentent aucun risque de grippe aviaire pour le consommateur, 2005. ,
Organisation Mondiale de la Santé animale) Code sanitaire pour la santé des animaux terrestres. Chapitre 4.13 : élimination des carcasses ,
Organisation Mondiale de la Santé animale) Code sanitaire pour la santé des animaux terrestres. Chapitre 7.6 : mise à mort d'animaux à des fins prophylactiques, 2009. ,